Assessing nivolumab in class II expressing microsatellite stable (pMMR) colorectal cancer (CRC): Results of the ANICCA-Class II trial
Middleton, G. Liu, W. Savage, J. Bridgewater, J. A. Ross, P. Saunders, Mark P Plummer, R. Clive, S. Coyle, V. Thomas, A.
Middleton, G.
Liu, W.
Savage, J.
Bridgewater, J. A.
Ross, P.
Saunders, Mark P
Plummer, R.
Clive, S.
Coyle, V.
Thomas, A.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Middleton G, Liu W, Savage J, Bridgewater JA, Ross P, Saunders MP, et al. Assessing nivolumab in class II expressing microsatellite stable (pMMR) colorectal cancer (CRC): Results of the ANICCA-Class II trial. Annals of Oncology. 2022 Sep;33(7):S729-S30. PubMed PMID: WOS:000866211600420.